Drug compound for preventing and curing diabetes mellitus
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
- Publication Date
- 2010-06-23
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a composition extracted from natural plants, in particular to a composition extracted from Anemarrhena and Phellodendron, for the prevention and treatment of diabetes. Background technique
[0002] Diabetes Mellitus (DM) is a series of clinical syndromes caused by absolute or relative insufficiency of insulin in the body. The disease will also cause some complications in the development process, such as: hypoglycemia (Hypoglycemia), ketoacidosis (Ketoacidosis), nonketotic hyperosmolar coma (Nonketotic Hyperosmolar Coma), cardiovascular disease, chronic renal failure, Retinopathy, neuropathy and microvascular disease. There are three main types of drugs commonly used in the treatment of diabetes: biological drugs, such as insulin (Insulin); chemical drugs, such as: sulfonylurea (Sulfonylurea), biguanide (Biguanide), glitazone (Glitazone) and Chinese patent medicine kind. Due to the lack of a relatively mature non-inje...